CTSC and skin squamous cell carcinoma: In summary, FC‐1, a dual‐enzyme cascade‐activated probe, was designed to exploit the endogenous upregulation of FAPα and CTSC in cSCC, facilitating accurate differential diagnosis and therapeutic assessment of cSCC.